Aeterna Zentaris Cash Conversion Cycle 2011-2026 | AEZS

Annual Cash Conversion Cycle Aeterna Zentaris

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	-	-	-	-34.3 K	51.5	23.3

All numbers in USD currency

Maximum	Minimum	Average
51.5	-34.3 K	-11.4 K

Issuer	Cash Conversion Cycle	Price	% 24h	Market Cap	Country
Acorda Therapeutics ACOR	117	-	-24.86 %	$ 820 K	USA
I-Mab IMAB	-1.97 K	-	-	$ 866 M	China
Akebia Therapeutics AKBA	42	$ 1.4	-0.71 %	$ 360 M	USA
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
EyeGate Pharmaceuticals, Inc. EYEG	17	-	-1.52 %	$ 24.7 M	USA
Aytu BioScience AYTU	174	$ 2.55	-0.78 %	$ 16 M	USA
Midatech Pharma plc MTP	82.8	-	-18.52 %	$ 27.3 M	Britain
AstraZeneca PLC AZN	-58	-	-	$ 96.9 B	Britain
Advaxis ADXS	-143 K	-	-9.65 %	$ 45.9 M	USA
Amphastar Pharmaceuticals AMPH	205	$ 20.37	-2.4 %	$ 952 M	USA
Aquestive Therapeutics AQST	-172	$ 4.08	-2.16 %	$ 436 M	USA
Ayala Pharmaceuticals AYLA	-2.15 K	-	-	$ 7.46 M	Israel
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
Arcutis Biotherapeutics ARQT	158	$ 24.21	-1.47 %	$ 3.08 B	USA
BeiGene, Ltd. BGNE	52.6	-	0.49 %	$ 251 B	Cayman-islands
AgeX Therapeutics AGE	186	-	-10.17 %	$ 12.2 K	USA
Celldex Therapeutics CLDX	-3.74 K	$ 32.24	-4.1 %	$ 2.14 B	USA
AIkido Pharma AIKI	-1.92	-	1.93 %	$ 17.4 M	USA
Avid Bioservices CDMO	85.5	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	2.26 K	-	-	$ 1.41 B	USA